Introducing ThinkCyte's MorphoScan Cloud: A New Era in AI-Driven Cell Analysis

ThinkCyte Unveils MorphoScan Cloud

On June 3, 2025, ThinkCyte, an innovative life science organization, made a significant announcement during the 38th Annual Congress of the International Society for the Advancement of Cytometry in Denver, Colorado. The company introduced MorphoScan Cloud, a versatile, cloud-based platform designed to facilitate AI-driven analysis of cell morphology data, marking an important advancement in the realm of biological research.

MorphoScan Cloud is engineered to enhance the existing capabilities of ThinkCyte's flagship product, VisionSort, a leading morphometric cell analysis and sorting platform. One of its standout features is secure cloud storage that permits rapid data processing and analysis. It allows research teams operating from multiple locations to centralize and share VisionSort-generated data in a more streamlined and efficient manner. This transformative process is essential for modern-day life sciences, where collaboration and data exchange can significantly accelerate research outcomes.

The platform encompasses a suite of advanced analytical tools tailored for extracting profound biological insights from complex cellular datasets. Users can adopt either supervised or unsupervised learning techniques through MorphoScan Cloud, which is enriched with advanced algorithms including deep learning. This empowers researchers to delve deeper into their data, enabling a fresh perspective on biological research and cellular analysis.

Waichiro Katsuda, CEO of ThinkCyte, expressed enthusiasm about the launch, highlighting that MorphoScan Cloud is more than just a data storage solution. “We’re providing our customers with an intelligent platform that fundamentally alters the interaction with cellular data,” Katsuda remarked. By blending VisionSort’s new biological insights with cloud accessibility and AI analytical prowess, ThinkCyte aims to revolutionize data analysis workflows in life sciences, thereby accelerating both discovery and innovation.

At CYTO 2025, attendees have the unique opportunity to witness MorphoScan Cloud in action at the ThinkCyte exhibit booth (#627). Interested individuals can discover further information about the platform by visiting ThinkCyte's official site.

About ThinkCyte

Established in 2016, ThinkCyte has positioned itself as a pioneering force in the biotechnology space with offices in Tokyo, Japan, and Redwood City, California. The company is dedicated to designing innovative scientific research platforms that integrate multi-disciplinary technologies aimed at bolstering life science research, diagnostics, and the development of therapies. ThinkCyte is renowned for its proprietary Ghost Cytometry™ technology, an AI-based, label-free cell analysis and sorting innovation. Collaborating closely with leading academic institutions and global pharmaceutical companies enables ThinkCyte to drive groundbreaking research forward. For more information about ThinkCyte, visit their website at www.thinkcyte.com.